Early Diagnosis
10
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era
The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients
The Biomarker Prediction Model of Septic Risk in Infected Patients
Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy
CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
Culture System for Isolating Circulating Tumor cells_2
Role of Genomic Imprinting in Cancer Diagnosis
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination